Midway while sailing across the Pacific with just his cat named Phoenix, Oliver Widger reflected on why he thinks his many followers — more than a million on TikTok and Instagram — are drawn ...

We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take a look at where Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stands ...

Pacific Biosciences PACB has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ...

- Announced new clinical data for two programs utilizing ARCUS validating safety and efficacy for Precision’s in vivo gene editing approach - Announced initial data from first cohort in the ...

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at where Cogent Biosciences, Inc. (NASDAQ:COGT) stands against other best ...

MENLO PARK, Calif. - Pacific Biosciences of California, Inc. (NASDAQ: PACB), known as PacBio, announced Monday that an independent investigation led by its Special Committee found no evidence of ...

(MENAFN- GlobeNewsWire - Nasdaq) MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the“Special ...

PacBio (Nasdaq: PACB), announced it plans to improve on its already highly accurate methylation detection capabilities in HiFi chemistry through licensing advanced DNA methylation detection methods ...

Comparative Analysis of Generative Pre-Trained Transformer Models in Oncogene-Driven Non–Small Cell Lung Cancer: Introducing the Generative Artificial Intelligence Performance Score We analyzed 203 ...

Senior Department of Defense leaders in both the Biden and Trump administrations agree that the Chinese Communist Party poses the greatest threat to the United States. One senator has made it his ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 15 cents in first-quarter 2025, narrower than the year-ago adjusted loss of 26 ...